中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共5条，第1-5条

帮助

条数/页：排序方式：
	Furmonertinib (Alflutinib, AST2818) is a potential positive control drug comparable to rifampin for evaluation of CYP3A4 induction in sandwich-cultured primary human hepatocytes 期刊论文 OAI收割 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 10 作者: Wu, Ya-li; Xue, Ya-ru; Guo, Zi-tao; Chen, Zhen-dong; Ge, Xin-yu \| 收藏 \| 浏览/下载：74/0 \| 提交时间：2021/08/17 furmonertinib (alflutinib AST2818) quantitative proteomics sandwich-cultured human hepatocytes
	Effects of rifampicin on the pharmacokinetics of alflutinib, a selective third-generation EGFR kinase inhibitor, and its metabolite AST5902 in healthy volunteers 期刊论文 OAI收割 INVESTIGATIONAL NEW DRUGS, 2021, 页码: 8 作者: Zhu, Yun-ting; Zhang, Yi-fan; Jiang, Jin-fang; Yang, Yong; Guo, Li-xia \| 收藏 \| 浏览/下载：41/0 \| 提交时间：2021/05/24 Alflutinib Rifampicin CYP3A4 AST5902 Drug-drug interaction
	Safety, Clinical Activity, and Pharmacokinetics of Al flutinib (AST2818) in Patients With Advanced NSCLC With EGFR T790M Mutation 期刊论文 OAI收割 JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15, 期号: 6, 页码: 1015-1026 作者: Shi, Yuankai; Zhang, Shucai; Hu, Xingsheng; Feng, Jifeng; Ma, Zhiyong \| 收藏 \| 浏览/下载：103/0 \| 提交时间：2020/12/24 Alflutinib NSCLC EGFR T790M mutation Efficacy Safety
	Alflutinib (AST2818), primarily metabolized by CYP3A4, is a potent CYP3A4 inducer 期刊论文 OAI收割 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 11 作者: Liu, Xiao-yun; Guo, Zi-tao; Chen, Zhen-dong; Zhang, Yi-fan; Zhou, Jia-lan \| 收藏 \| 浏览/下载：112/0 \| 提交时间：2020/07/01 alflutinib AST5902 metabolism enzyme induction drug-drug interaction
	Simultaneous determination of alflutinib and its active metabolite in human plasma using liquid chromatography-tandem mass spectrometry 期刊论文 OAI收割 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 卷号: 176, 页码: 6 作者: Liu, Xiaoyun; Li, Wei; Zhang, Yifan; Jian, Yong; Zhao, Qianyu \| 收藏 \| 浏览/下载：56/0 \| 提交时间：2020/07/01 LC-MS/MS Alflutinib AST2818 Pharmacokinetics Human plasma